Coste Catherine
CIK 0001821432
Director
Filings
9
Latest Feb 26, 2026
Issuers covered
4
Showing
9 of 9
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -11.0% | -11.0% | -11.0% | -11.0% |
| 90 days | 1 | 0% | -58.7% | -58.7% | -58.7% | -58.7% |
| 180 days | 1 | 0% | -53.3% | -53.3% | -53.3% | -53.3% |
| 365 days | 1 | 0% | -70.0% | -70.0% | -70.0% | -70.0% |
Issuers
Companies where Coste Catherine has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BMRA | Biomerica Inc | 4 | Dec 17, 2024 |
| BLFS | Biolife Solutions Inc | 2 | Feb 26, 2026 |
| RNLX | Renalytix PLC | 2 | Nov 22, 2023 |
| UTRS | Minerva Surgical Inc | 1 | Jun 14, 2022 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|